Skip to main content
SpringerLink
Log in

Diffuse structural and metabolic brain changes in Fabry disease

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Objectives

To assess structural and metabolic brain changes in subjects affected by Fabry disease (FD) or carrying the disease mutation.

Background

FD is an X–linked metabolic disorder due to α-galactosidase A deficiency, which leads to storage of glycosphingolipids in many tissues and organs. Previous MR studies have shown structural and metabolic brain abnormalities in FD patients. It is not clear, however, whether tissue damage can be seen in both the brains of hemizygous and heterozygous and whether quantitative MR metrics are useful to monitor disease evolution.

Design/Methods

We studied 4 males and 4 females with FD. Each subject underwent brain proton MRI/MR spectroscopic imaging (MRSI) examinations to obtain measures of total brain volumes, total brain lesion volumes, magnetization transfer ratios (MTr) in WM and central brain levels of N–acetylaspartate (NAA) to creatine (Cr). A second MR examination was performed in five subjects after 2 years.

Results

Focal WM lesions were found in 2 males and 1 female. The MTr values were always low in the WM lesions of FD subjects (p < 0.001) and also were low in the normal–appearing WM of 2 affected males. Total brain volumes were never decreased in FD subjects. Brain NAA/Cr values were significantly (p = 0.005) lower in FD subjects than in normal controls and correlated closely with Rankin scale measures (r = –0.79). On follow–up examinations, no significant MR changes were found. However, the small changes in NAA/Cr correlated closely with changes in Rankin scores (r = –0.86).

Conclusions

Subtle structural and metabolic tissue damage can extend beyond WM lesions in FD subjects. Diffuse brain NAA/Cr decrease can be found in FD subjects in relation to the degree of their CNS involvement and its evolution over time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bagley LJ, McGowan JC, Grossman RI, Sinson G, Kotapka M, Lexa FJ, et al. (2000) Magnetization transfer imaging of traumatic brain injury. J Magn Reson Imaging 11:1–8

    Article  CAS  PubMed  Google Scholar 

  2. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD (2002) N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 51:51–58

    Article  CAS  PubMed  Google Scholar 

  3. Borsini W, Giuliacci G, Torricelli F, Pelo E, Martinelli F, Scordo MR (2002) Anderson- Fabry disease with cerebrovascular complications in two Italian families. Neurol Sci 23:49–53

    Article  CAS  PubMed  Google Scholar 

  4. Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. JAMA 284:2771–2775

    Article  CAS  PubMed  Google Scholar 

  5. Brenner RE, Munro PM, Williams SC, Bell JD, Barker GJ, Hawkins CP, et al. (1993) The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 29:737–745

    CAS  PubMed  Google Scholar 

  6. Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, et al. (1998) Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50:1746–1749

    CAS  PubMed  Google Scholar 

  7. de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N (1995) The clinical meaning of Rankin ‘handicap’ grades after stroke. Stroke 26:2027–2030

    CAS  PubMed  Google Scholar 

  8. De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 34:721–727

    CAS  PubMed  Google Scholar 

  9. De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, et al. (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58:65–70

    Article  CAS  PubMed  Google Scholar 

  10. De Stefano N, Narayanan S, Matthews PM, Mortilla M, Dotti MT, Federico A, et al. (2000) Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. J Neurovirol 6 (Suppl 2):121–129

    Google Scholar 

  11. Eng CM, Desnick RJ (1994) Molecular basis of Fabry disease: mutations and polymorphisms in the human alphagalactosidase A gene. Hum Mutat 3:103–111

    Article  CAS  PubMed  Google Scholar 

  12. Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N, et al. (1995) A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45:478–482

    CAS  PubMed  Google Scholar 

  13. Fox NC, Schott JM (2004) Imaging cerebral atrophy: normal ageing to Alzheimer’s disease. Lancet 363:392–394

    Article  PubMed  Google Scholar 

  14. Grewal RP, McLatchey SK (1992) Cerebrovascular manifestations in a female carrier of Fabry’s disease. Acta Neurol Belg 92:36–40

    CAS  PubMed  Google Scholar 

  15. Grossman RI, Gomori JM, Ramer KN, Lexa FJ, Schnall MD (1994) Magnetization transfer: theory and clinical applications in neuroradiology. Radio Graphics 14:279–290

    CAS  Google Scholar 

  16. Hanyu H, Asano T, Sakurai H, Iwamoto T, Takasaki M, Shindo H, et al. (1999) Magnetization transfer ratio in cerebral white matter lesions of Binswanger’s disease. J Neurol Sci 166:85–90

    Article  CAS  PubMed  Google Scholar 

  17. Iannucci G, Dichgans M, Rovaris M, Bruning R, Gasser T, Giacomotti L, et al. (2001) Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 32:643–648

    CAS  PubMed  Google Scholar 

  18. Jardim L, Vedolin L, Schwartz IV, Burin MG, Cecchin C, Kalakun L, et al. (2004) CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy. J Inherit Metab Dis 27:229–240

    Article  CAS  PubMed  Google Scholar 

  19. Kado H, Kimura H, Tsuchida T, Yonekura Y, Tokime T, Tokuriki Y, et al. (2001) Abnormal magnetization transfer ratios in normal-appearing white matter on conventional MR images of patients with occlusive cerebrovascular disease. AJNR Am J Neuroradiol 22:922–927

    CAS  PubMed  Google Scholar 

  20. Kaye EM, Kolodny EH, Logigian EL, Ullman MD (1988) Nervous system involvement in Fabry’s disease: clinicopathological and biochemical correlation. Ann Neurol 23:505–509

    Article  CAS  PubMed  Google Scholar 

  21. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676–1695

    Article  PubMed  Google Scholar 

  22. Mitsias P, Levine SR (1996) Cerebrovascular complications of Fabry’s disease. Ann Neurol 40:8–17

    Article  CAS  PubMed  Google Scholar 

  23. Moore DF, Altarescu G, Barker WC, Patronas NJ, Herscovitch P, Schiffmann R (2003) White matter lesions in Fabry disease occur in ‘prior’ selectively hypometabolic and hyperperfused brain regions. Brain Res Bull 62:231–240

    Article  CAS  PubMed  Google Scholar 

  24. Moore DF, Ye F, Schiffmann R, Butman JA (2003) Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol 24:1096–1101

    PubMed  Google Scholar 

  25. Narayanan S, De Stefano N, Francis GS, Arnaoutelis R, Caramanos Z, Collins DL, et al. (2001) Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol 248:979–986

    Article  CAS  PubMed  Google Scholar 

  26. Pike GB, De Stefano N, Narayanan S, Francis GS, Antel JP, Arnold DL (1999) Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol 20:829–837

    CAS  PubMed  Google Scholar 

  27. Pike GB, Glover GH, Hu BS, Enzmann DR (1993) Pulsed magnetization transfer spin-echo MR imaging. J Magn Reson Imaging 3:531–539

    CAS  PubMed  Google Scholar 

  28. Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L (1999) Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS.Multiple Sclerosis Collaborative Research Group. Neurology 53:1698–1704

    CAS  PubMed  Google Scholar 

  29. Sachdev P (2004) Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 226:25–29

    Article  CAS  PubMed  Google Scholar 

  30. Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37–45

    Article  CAS  PubMed  Google Scholar 

  31. Smith SM, De Stefano N, Jenkinson M, Matthews PM (2001) Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomograph 25:466–475

    Article  CAS  Google Scholar 

  32. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al. (2002) Accurate, robust and automated longitudinal and cross-sectional brain change analysis. NeuroImage 17:479–489

    Article  PubMed  Google Scholar 

  33. Takanashi J, Barkovich AJ, Dillon WP, Sherr EH, Hart KA, Packman S (2003) T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease. AJNR Am J Neuroradiol 24:916–921

    PubMed  Google Scholar 

  34. Tanabe JL, Ezekiel F, Jagust WJ, Reed BR, Norman D, Schuff N, et al. (1999) Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. AJNR Am J Neuroradiol 20:839–844

    CAS  PubMed  Google Scholar 

  35. Tedeschi G, Bonavita S, Banerjee TK, Virta A, Schiffmann R (1999) Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study. Neurology 52:1663–1667

    CAS  PubMed  Google Scholar 

  36. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, et al. (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516–524

    Article  CAS  PubMed  Google Scholar 

  37. van der Flier WM, van Buchem MA, van Buchem HA (2003) Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 60:1558–1559

    PubMed  Google Scholar 

  38. van der Flier WM, van den Heuvel DM, Weverling-Rijnsburger AW, Spilt A, Bollen EL, Westendorp RG, et al. (2002) Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 59:874–879

    CAS  PubMed  Google Scholar 

  39. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, et al. (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46:747–754

    Article  CAS  PubMed  Google Scholar 

  40. Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone, et al. (1995) Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy (letter). Lancet 345:60–61

    Article  CAS  PubMed  Google Scholar 

  41. Walters RJ, Fox NC, Schott JM, Crum WR, Stevens JM, Rossor MN, et al. (2003) Transient ischaemic attacks are associated with increased rates of global cerebral atrophy. J Neurol Neurosurg Psychiatry 74:213–216

    Article  CAS  PubMed  Google Scholar 

  42. Whybra C, Kampmann C, Willers I, Davies J, Winchester B, Kriegsmann J, et al. (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 24:715–724

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Studi Neurolesi, Medical School University of Messina, Italy

    S. Marino MD & P. Bramanti MD

  2. Department of Neurology and Psychiatry, University of Florence, Italy

    W. Borsini MD & S. Buchner MD

  3. Department of Radiology, Children Hospital Anna Meyer, Florence, Italy

    M. Mortilla MD

  4. Neurology & Neurometabolic Unit, Dept. Neurological and Behavioral Sciences University of Siena, Viale Bracci 2, 53100, Siena, Italy

    S. Marino MD, M. Mortilla MD, M. L. Stromillo MD, M. Battaglini MSc, A. Giorgio MD, A. Federico MD & N. De Stefano MD

Authors
  1. S. Marino MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Borsini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Buchner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Mortilla MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. L. Stromillo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Battaglini MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Giorgio MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Bramanti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Federico MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. N. De Stefano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marino, S., Borsini, W., Buchner, S. et al. Diffuse structural and metabolic brain changes in Fabry disease. J Neurol 253, 434–440 (2006). https://doi.org/10.1007/s00415-005-0020-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0020-z

Key words

Search

Navigation